Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCC4 EST170205, MOAT-B, MOATB, MRP4 ENSG00000125257 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13 95019829-95301446 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA002476 Supported Approved Nucleoli
Plasma membrane
Cytosol Renal cancer:2.25e-10 (favourable), Endometrial cancer:9.89e-4 (unfavourable) Tissue enriched Tissue enhanced prostate: 68.5 epididymis: 23.3 ABCC8 ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2 ENSG00000006071 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 11 17392885-17476845 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level CAB011451, HPA042318 Approved Approved Nucleoli
Golgi apparatus
Cytosol Tissue enriched Tissue enhanced cerebral cortex: 11.7 adrenal gland: 7.6 ABHD14B CIB, MGC15429 ENSG00000114779 Abhydrolase domain containing 14B 3 51968510-51983409 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA036444, HPA036642 Supported Supported Nucleus
Nucleoli
Cytosol Renal cancer:2.93e-5 (favourable), Endometrial cancer:5.42e-5 (favourable), Cervical cancer:6.92e-5 (favourable) Expressed in all Expressed in all thyroid gland: 90.5 AC004381.6 ENSG00000005189 Putative RNA exonuclease NEF-sp 16 20806429-20849668 Predicted intracellular proteins Evidence at protein level HPA040755, HPA040868 Supported Approved Nuclear membrane
Nucleoli
Endoplasmic reticulum Expressed in all Tissue enriched 33 testis: 615.7 parathyroid gland: 18.5 ACADVL ACAD6, LCACD, VLCAD ENSG00000072778 Acyl-CoA dehydrogenase, very long chain 17 7217125-7225273 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA019006, HPA020595 Supported Supported Nucleus
Nucleoli
Mitochondria Pancreatic cancer:6.87e-4 (favourable) Expressed in all Expressed in all adrenal gland: 455.8 AEN FLJ12484, FLJ12562, ISG20L1 ENSG00000181026 Apoptosis enhancing nuclease 15 88621296-88632282 Predicted intracellular proteins Evidence at protein level HPA048599 Supported Nucleus
Nuclear membrane
Nucleoli Endometrial cancer:1.72e-4 (favourable) Expressed in all Mixed gallbladder: 19.8 AGAP2 CENTG1 ENSG00000135439 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 12 57723761-57742157 Predicted intracellular proteins Evidence at protein level HPA023474 Approved Supported Nucleus
Nucleoli
Mitochondria Tissue enriched Tissue enriched 7 cerebral cortex: 145.0 lymph node: 20.1 AGPAT4 dJ473J16.2, LPAAT-delta ENSG00000026652 1-acylglycerol-3-phosphate O-acyltransferase 4 6 161129979-161274061 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA053287, HPA060525 Approved Approved Nucleoli
Golgi apparatus
Vesicles Cervical cancer:1.45e-4 (unfavourable), Renal cancer:4.08e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 24.8 placenta: 12.2 AKAP11 AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11 ENSG00000023516 A kinase (PRKA) anchor protein 11 13 42272153-42323267 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039089 Supported Approved Nucleoli
Plasma membrane
Cytosol Cervical cancer:9.26e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 51.7 ANKRD49 FGIF, FLJ20189, GBIF ENSG00000168876 Ankyrin repeat domain 49 11 94493629-94499583 Predicted intracellular proteins Evidence at protein level HPA040273, HPA048137 Approved Approved Nucleus
Nucleoli
Golgi apparatus Urothelial cancer:6.16e-4 (favourable), Renal cancer:9.96e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 25.2 ANKS6 ANKRD14, FLJ36928, NPHP16, SAMD6 ENSG00000165138 Ankyrin repeat and sterile alpha motif domain containing 6 9 98731329-98796965 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA008355 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:3.44e-5 (favourable) Expressed in all Mixed thyroid gland: 15.3 ANXA10 ANX14 ENSG00000109511 Annexin A10 4 168092515-168187690 Predicted intracellular proteins Evidence at protein level HPA005469 Supported Approved Nucleus
Nucleoli
Vesicles Liver cancer:3.64e-6 (favourable) Group enriched Tissue enriched 7 stomach: 460.7 urinary bladder: 62.8 ATAD1 FLJ14600 ENSG00000138138 ATPase family, AAA domain containing 1 10 87751512-87841343 Enzymes, Predicted membrane proteins Evidence at protein level HPA037569 Uncertain Approved Nucleus
Nucleoli
Mitochondria Renal cancer:3.98e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 28.5 ATP13A3 AFURS1 ENSG00000133657 ATPase type 13A3 3 194402672-194498364 Predicted membrane proteins Evidence at protein level HPA029471 Approved Approved Nucleoli
Plasma membrane
Cytosol Pancreatic cancer:1.60e-4 (unfavourable), Renal cancer:1.63e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 146.4 ATXN1 ATX1, D6S504E, SCA1 ENSG00000124788 Ataxin 1 6 16299112-16761491 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA008335, HPA070756 Approved Supported Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all cerebral cortex: 17.5 ATXN3 ATX3, JOS, MJD, SCA3 ENSG00000066427 Ataxin 3 14 92038652-92106621 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB021976, HPA024123, HPA069338 Uncertain Supported Nucleus
Nucleoli
Plasma membrane Mixed Mixed testis: 18.5 ATXN7L2 FLJ00381, MGC46534 ENSG00000162650 Ataxin 7-like 2 1 109483479-109492804 Predicted intracellular proteins Evidence at protein level HPA029827, HPA054952 Uncertain Approved Nucleoli
Vesicles
Cytosol Renal cancer:1.19e-8 (unfavourable), Endometrial cancer:7.65e-4 (unfavourable) Expressed in all Mixed testis: 4.3 BMP7 OP-1 ENSG00000101144 Bone morphogenetic protein 7 20 57168748-57266629 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA057757 Approved Nucleus
Nucleoli
Vesicles Endometrial cancer:2.91e-4 (unfavourable) Mixed Tissue enhanced thyroid gland: 76.4 placenta: 36.6 BRWD1 C21orf107, DCAF19, FLJ11315, N143, WDR9 ENSG00000185658 Bromodomain and WD repeat domain containing 1 21 39184176-39321559 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA030943, HPA030944, HPA030945, CAB034184 Approved Supported Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all cerebral cortex: 77.9 C15orf43 MGC33951 ENSG00000167014 Chromosome 15 open reading frame 43 15 44956702-44979229 Predicted intracellular proteins Evidence at protein level HPA041780, HPA041941 Uncertain Nucleus
Nucleoli
Centrosome Not detected Tissue enriched 22 testis: 39.9 breast: 1.7 C15orf61 LOC145853 ENSG00000189227 Chromosome 15 open reading frame 61 15 67521068-67530143 Predicted intracellular proteins Evidence at protein level HPA062820 Approved Nucleoli
Vesicles
Cytosol Renal cancer:5.31e-5 (favourable) Expressed in all Mixed cerebral cortex: 11.0 C1orf131 DKFZp547B1713 ENSG00000143633 Chromosome 1 open reading frame 131 1 231223763-231241187 Predicted intracellular proteins Evidence at protein level HPA028452, HPA029920 Approved Validated Nucleus
Nucleoli
Cytosol Renal cancer:2.64e-9 (unfavourable), Urothelial cancer:9.84e-4 (favourable) Expressed in all Expressed in all duodenum: 22.2 C8orf34 vest-1, VEST1 ENSG00000165084 Chromosome 8 open reading frame 34 8 68330722-68819022 Predicted intracellular proteins Evidence at protein level HPA044420, HPA053065 Uncertain Supported Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enhanced fallopian tube: 15.1;parathyroid gland: 19.7 cerebral cortex: 6.1 C8orf59 ENSG00000176731 Chromosome 8 open reading frame 59 8 85214076-85220421 Predicted intracellular proteins Evidence at protein level HPA044805, HPA071903 Approved Nucleus
Nucleoli
Cytosol Renal cancer:0.00e+0 (unfavourable) Expressed in all Expressed in all breast: 119.7 C9orf85 MGC61599 ENSG00000155621 Chromosome 9 open reading frame 85 9 71911510-71986054 Predicted intracellular proteins Evidence at protein level HPA050767 Approved Nucleus
Nucleoli
Golgi apparatus Expressed in all Expressed in all thyroid gland: 13.9 CA13 CAXIII, FLJ37995, MGC59868 ENSG00000185015 Carbonic anhydrase XIII 8 85220587-85284073 Enzymes, Predicted intracellular proteins Evidence at protein level HPA024689, CAB025567 Approved Uncertain Nucleus
Nucleoli
Vesicles Renal cancer:9.40e-4 (favourable) Expressed in all Mixed small intestine: 16.9 CAMLG CAML, GET2 ENSG00000164615 Calcium modulating ligand 5 134738501-134752160 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA052636, HPA056472 Approved Approved Nucleus
Nucleoli
Vesicles Renal cancer:1.09e-5 (unfavourable) Expressed in all Expressed in all testis: 99.0 CAPS2 ENSG00000180881 Calcyphosine 2 12 75275979-75390928 Predicted intracellular proteins Evidence at transcript level HPA040004 Uncertain Approved Nucleus
Nucleoli
Centrosome Mixed Tissue enhanced fallopian tube: 15.6 testis,thyroid gland: 6.8 CATSPERG C19orf15, DKFZp434A1022, FLJ46353 ENSG00000099338 Catsper channel auxiliary subunit gamma 19 38335775-38370943 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA052777 Approved Nucleus
Nucleoli
Cytosol Mixed Tissue enriched 41 testis: 48.5 skin: 1.1 CCDC175 C14orf38 ENSG00000151838 Coiled-coil domain containing 175 14 59504539-59576831 Predicted intracellular proteins Evidence at protein level HPA004200 Uncertain Approved Nucleus
Nucleoli
Cytosol Not detected Tissue enriched 8 testis: 4.0 fallopian tube,rectum: 0.4 CDCA7L JPO2, R1, RAM2 ENSG00000164649 Cell division cycle associated 7-like 7 21900900-21946084 Predicted intracellular proteins Evidence at protein level HPA027169 Approved Supported Nucleus
Nucleoli
Cytosol Liver cancer:4.36e-6 (unfavourable), Renal cancer:1.98e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 45.8 CDV3 H41 ENSG00000091527 CDV3 homolog (mouse) 3 133573730-133590261 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA029761, HPA029762, HPA029763 Supported Validated Nucleoli
Plasma membrane
Cytosol Liver cancer:5.21e-6 (unfavourable) Expressed in all Expressed in all lymph node: 187.9 CEACAM19 CEAL1 ENSG00000186567 Carcinoembryonic antigen-related cell adhesion molecule 19 19 44662278-44684359 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA014462, HPA052865 Uncertain Approved Nucleus
Nucleoli
Mitochondria Expressed in all Mixed skin: 12.7 CEP85 CCDC21, DKFZP434L0117 ENSG00000130695 Centrosomal protein 85kDa 1 26234153-26279038 Predicted intracellular proteins Evidence at protein level HPA028252 Approved Supported Nucleoli
Golgi apparatus
Cytosol Liver cancer:4.39e-6 (unfavourable) Expressed in all Tissue enhanced skeletal muscle: 34.1;testis: 44.1 heart muscle: 12.9 CERCAM CEECAM1, CerCAM, GLT25D3 ENSG00000167123 Cerebral endothelial cell adhesion molecule 9 128411751-128437351 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA021657, HPA051595 Uncertain Approved Nucleus
Nucleoli
Cell Junctions Renal cancer:3.33e-16 (unfavourable), Urothelial cancer:3.30e-5 (unfavourable), Ovarian cancer:5.22e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 156.0 CFAP97 DKFZp434F1728, hmw, KIAA1430 ENSG00000164323 Cilia and flagella associated protein 97 4 185159665-185209504 Predicted intracellular proteins Evidence at protein level HPA049446, HPA053335 Approved Supported Nucleoli
Plasma membrane
Cytosol Expressed in all Expressed in all testis: 67.5 CHD3 Mi-2a, Mi2-ALPHA, ZFH ENSG00000170004 Chromodomain helicase DNA binding protein 3 17 7884806-7912760 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA043368, HPA076524 Supported Approved Nucleus
Nucleoli
Microtubule organizing center Endometrial cancer:7.68e-5 (favourable), Colorectal cancer:2.43e-4 (unfavourable), Pancreatic cancer:8.36e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 83.9 CIPC KIAA1737 ENSG00000198894 CLOCK-interacting pacemaker 14 77098097-77117287 Predicted intracellular proteins Evidence at protein level HPA000644 Supported Nucleus
Nucleoli
Cytosol Renal cancer:1.77e-10 (favourable) Expressed in all Expressed in all cerebral cortex: 54.5 CKAP5 ch-TOG, KIAA0097, TOG, TOGp ENSG00000175216 Cytoskeleton associated protein 5 11 46743048-46846308 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039377, HPA040375 Supported Approved Nucleoli
Plasma membrane
Cytosol Liver cancer:1.03e-6 (unfavourable) Expressed in all Expressed in all cerebral cortex: 66.4 CLDND1 C3orf4 ENSG00000080822 Claudin domain containing 1 3 98497912-98523066 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA029841 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:5.84e-6 (unfavourable) Expressed in all Expressed in all cerebral cortex: 400.9 COX10 ENSG00000006695 COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor 17 14069496-14208677 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA032005, HPA032006 Supported Supported Nucleoli
Mitochondria
Cytosol Renal cancer:4.32e-6 (favourable), Stomach cancer:8.73e-4 (favourable) Expressed in all Expressed in all testis: 43.0 CPT2 CPT1, CPTASE ENSG00000157184 Carnitine palmitoyltransferase 2 1 53196429-53214197 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA028201, HPA028202, HPA028214 Supported Supported Nucleoplasm
Nucleoli
Mitochondria Renal cancer:1.46e-12 (favourable), Colorectal cancer:5.27e-4 (favourable) Expressed in all Expressed in all liver: 42.1 CRAMP1 CRAMP1L, KIAA1426 ENSG00000007545 Cramped chromatin regulator homolog 1 16 1612325-1677908 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041752 Uncertain Approved Nucleus
Nucleoli
Cytosol Stomach cancer:4.93e-4 (favourable) Expressed in all Mixed testis: 31.8 CRIP2 CRP2, ESP1 ENSG00000182809 Cysteine-rich protein 2 14 105472962-105480170 Predicted intracellular proteins Evidence at protein level HPA042664 Approved Approved Nucleus
Nucleoli
Plasma membrane Expressed in all Tissue enhanced heart muscle: 343.0 fallopian tube: 114.8 CYB5D2 MGC32124 ENSG00000167740 Cytochrome b5 domain containing 2 17 4143168-4187310 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042299 Approved Approved Nuclear membrane
Nucleoli
Centrosome Renal cancer:2.03e-10 (favourable), Liver cancer:4.98e-6 (favourable), Pancreatic cancer:7.76e-5 (favourable), Endometrial cancer:6.19e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 51.5 CYB5R1 humb5R2, NQO3A2 ENSG00000159348 Cytochrome b5 reductase 1 1 202961869-202967280 Enzymes, Predicted intracellular proteins Evidence at protein level HPA010641, HPA014147 Supported Uncertain Nucleoli
Mitochondria
Cytosol Endometrial cancer:1.14e-4 (favourable) Expressed in all Expressed in all skeletal muscle: 183.8 DAB2 DOC-2 ENSG00000153071 Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) 5 39371675-39462300 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB009314, HPA028888 Supported Supported Nucleoli
Vesicles
Plasma membrane Liver cancer:7.38e-6 (unfavourable), Stomach cancer:9.67e-4 (unfavourable) Expressed in all Expressed in all placenta: 319.5 DCTN6 WS-3 ENSG00000104671 Dynactin 6 8 30156297-30183640 Predicted intracellular proteins Evidence at protein level HPA024049, HPA024558 Approved Supported Nucleoli
Plasma membrane
Cytosol Renal cancer:5.42e-4 (favourable), Liver cancer:5.51e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 94.2 DDAH1 DDAH ENSG00000153904 Dimethylarginine dimethylaminohydrolase 1 1 85318481-85578363 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA006308 Supported Approved Nucleoli
Plasma membrane
Cytosol Renal cancer:5.21e-6 (favourable), Colorectal cancer:5.99e-4 (favourable) Expressed in all Mixed kidney: 119.5 DDX28 FLJ11282, MDDX28 ENSG00000182810 DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 16 68021274-68023442 Enzymes, Predicted secreted proteins Evidence at protein level HPA041911, HPA053585 Approved Supported Nucleoli
Mitochondria
Cytosol Renal cancer:2.07e-10 (favourable) Expressed in all Expressed in all bone marrow: 11.2 DDX31 FLJ13633, FLJ14578, FLJ23349, PPP1R25 ENSG00000125485 DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 9 132592997-132670401 Enzymes, Predicted intracellular proteins Evidence at protein level HPA020891 Supported Nucleoli
Golgi apparatus
Vesicles Liver cancer:1.68e-7 (unfavourable) Expressed in all Expressed in all thyroid gland: 23.0 DDX51 ENSG00000185163 DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 12 132136594-132144335 Enzymes, Predicted intracellular proteins Evidence at protein level HPA039503 Uncertain Approved Nucleus
Nucleoli
Cytosol Liver cancer:4.73e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 11.4 DDX54 APR-5, DP97, MGC2835 ENSG00000123064 DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 12 113157174-113185479 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA028244, HPA070786 Approved Approved Nucleus
Nucleoli
Golgi apparatus Liver cancer:1.39e-4 (unfavourable) Expressed in all Expressed in all appendix: 40.2 DDX55 KIAA1595 ENSG00000111364 DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 12 123602077-123620941 Enzymes, Predicted intracellular proteins Evidence at protein level HPA039962, HPA044101 Approved Supported Nucleus
Nucleoli
Cytosol Renal cancer:8.97e-12 (unfavourable), Liver cancer:2.11e-9 (unfavourable) Expressed in all Expressed in all skin: 16.5 DEPDC7 ENSG00000121690 DEP domain containing 7 11 33015864-33033582 Predicted intracellular proteins Evidence at protein level HPA015800 Approved Nucleus
Nucleoli
Cytosol Liver cancer:7.26e-4 (favourable) Mixed Tissue enhanced liver: 37.5;testis: 50.4 small intestine: 31.9 DIAPH2 DIA, DIA2, POF, POF2 ENSG00000147202 Diaphanous-related formin 2 X 96684663-97604997 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA005647, CAB015461, CAB068183, CAB068184 Supported Supported Nucleoli
Endoplasmic reticulum
Vesicles Endometrial cancer:2.16e-5 (unfavourable), Pancreatic cancer:2.12e-4 (unfavourable), Renal cancer:3.90e-4 (unfavourable) Expressed in all Expressed in all placenta: 17.6 DIMT1 DIMT1L, HSA9761 ENSG00000086189 DIM1 dimethyladenosine transferase 1 homolog 5 62387254-62403939 Enzymes, Predicted intracellular proteins Evidence at protein level HPA042944 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:8.90e-12 (unfavourable), Liver cancer:6.93e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 33.8 DNAJA2 CPR3, DNAJ, DNJ3, HIRIP4 ENSG00000069345 DnaJ (Hsp40) homolog, subfamily A, member 2 16 46955362-46973788 Predicted intracellular proteins Evidence at protein level HPA049789, HPA060538 Approved Approved Nucleoli
Intermediate filaments
Cytosol Renal cancer:1.19e-9 (favourable), Head and neck cancer:2.81e-4 (unfavourable) Expressed in all Expressed in all testis: 41.8 DOC2A ENSG00000149927 Double C2-like domains, alpha 16 30005509-30023270 Predicted intracellular proteins Evidence at protein level HPA065676 Uncertain Nucleus
Nucleoli
Cell Junctions Tissue enhanced Group enriched 9 cerebral cortex: 69.9;testis: 21.0 ovary: 5.2 DRGX DRG11, PRRXL1 ENSG00000165606 Dorsal root ganglia homeobox 10 49364181-49396016 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043978 Uncertain Approved Nucleus
Nucleoli
Cytosol Mixed Tissue enriched 11 adrenal gland: 8.9 skin: 0.8 DTWD1 MDS009, MGC111207 ENSG00000104047 DTW domain containing 1 15 49620980-49656232 Predicted intracellular proteins Evidence at protein level HPA042214 Uncertain Approved Nucleus
Nucleoli
Vesicles Expressed in all Expressed in all endometrium: 39.5 DTX3 FLJ34766, RNF154 ENSG00000178498 Deltex 3, E3 ubiquitin ligase 12 57604622-57609804 Predicted intracellular proteins Evidence at protein level HPA059654 Approved Approved Nucleus
Nucleoli
Golgi apparatus Pancreatic cancer:1.44e-4 (favourable), Lung cancer:9.87e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 103.1 DUX4 ENSG00000260596 Double homeobox 4 4 190173774-190185942 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level HPA058451 Approved Nucleus
Nucleoli
Cytosol Not detected Tissue enhanced testis: 1.5 seminal vesicle: 0.5 E2F8 FLJ23311 ENSG00000129173 E2F transcription factor 8 11 19224063-19241620 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064882 Supported Nucleus
Nucleoli
Cytosol Mixed Mixed bone marrow: 9.2 ECEL1 DINE, XCE ENSG00000171551 Endothelin converting enzyme-like 1 2 232479827-232487828 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA067560 Approved Nucleoplasm
Nuclear membrane
Nucleoli Tissue enhanced Tissue enriched 24 ovary: 111.9 spleen: 4.6 ECHDC3 FLJ20909 ENSG00000134463 Enoyl CoA hydratase domain containing 3 10 11742366-11764070 Predicted intracellular proteins Evidence at protein level HPA038306 Supported Approved Nucleus
Nucleoli
Mitochondria Renal cancer:3.43e-4 (favourable), Urothelial cancer:3.91e-4 (unfavourable) Expressed in all Expressed in all adipose tissue: 76.3 EDN1 ET1 ENSG00000078401 Endothelin 1 6 12290363-12297194 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level HPA031976, CAB032500, CAB037291 Approved Approved Nucleus
Nucleoli
Golgi apparatus Expressed in all Mixed lung: 43.6 EFCAB14 KIAA0494 ENSG00000159658 EF-hand calcium binding domain 14 1 46675159-46719064 Predicted membrane proteins Evidence at protein level HPA011224, HPA011938 Supported Approved Nucleoli
Golgi apparatus
Cytosol Expressed in all Expressed in all parathyroid gland: 299.7 EHBP1L1 DKFZp762C186, TANGERIN ENSG00000173442 EH domain binding protein 1-like 1 11 65576038-65592650 Predicted intracellular proteins Evidence at protein level HPA039479 Approved Approved Nucleoli
Plasma membrane
Cytosol Renal cancer:1.45e-4 (unfavourable) Expressed in all Mixed skeletal muscle: 88.6 ELAVL1 Hua, HUR, MelG ENSG00000066044 ELAV like RNA binding protein 1 19 7958579-8445041 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB005256, HPA046298 Approved Supported Nucleus
Nucleoli
Cytosol Ovarian cancer:4.93e-4 (favourable) Expressed in all Expressed in all testis: 82.2 ELMOD2 MGC10084 ENSG00000179387 ELMO/CED-12 domain containing 2 4 140524158-140553770 Predicted intracellular proteins Evidence at protein level HPA047600 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:1.17e-8 (favourable), Thyroid cancer:6.35e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 28.0 EXOSC10 p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p ENSG00000171824 Exosome component 10 1 11066618-11099881 Predicted intracellular proteins Evidence at protein level HPA028470, HPA028484, CAB037141 Supported Supported Nucleus
Nucleoli
Cytosol Liver cancer:2.49e-6 (unfavourable), Thyroid cancer:5.27e-4 (favourable) Expressed in all Expressed in all endometrium: 46.5 FAM131C C1orf117, FLJ36766 ENSG00000185519 Family with sequence similarity 131, member C 1 16057769-16073632 Predicted intracellular proteins Evidence at protein level HPA031046 Uncertain Approved Nucleoli
Intermediate filaments
Cytosol Renal cancer:9.33e-6 (favourable) Mixed Tissue enhanced adrenal gland: 3.3;cerebral cortex: 4.8;kidney: 3.8 heart muscle: 1.2 FAM13A ARHGAP48, FAM13A1, KIAA0914 ENSG00000138640 Family with sequence similarity 13, member A 4 88725955-89111398 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA038108, HPA038109 Uncertain Approved Nucleoli
Cell Junctions
Cytosol Urothelial cancer:4.28e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 113.3 FAM21A bA56A21.1, bA98I6.1, FAM21B, FLJ10824 ENSG00000099290 Family with sequence similarity 21, member A 10 50067888-50133506 Predicted intracellular proteins Evidence at protein level HPA047844, HPA060975 Approved Supported Nucleoli
Vesicles
Cytosol Liver cancer:6.75e-5 (unfavourable) Expressed in all Expressed in all heart muscle: 45.0 FAM21C Em:AC012044.3, KIAA0592 ENSG00000172661 Family with sequence similarity 21, member C 10 45727200-45792961 Predicted intracellular proteins Evidence at protein level HPA047844, HPA060975 Approved Supported Nucleoli
Vesicles
Cytosol Liver cancer:1.35e-5 (unfavourable), Lung cancer:4.69e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 41.2 FAM229B C6orf225, DKFZp586F0922, LOC619208 ENSG00000203778 Family with sequence similarity 229, member B 6 112087599-112102790 Predicted intracellular proteins Evidence at transcript level HPA036068 Approved Nucleus
Nucleoli
Golgi apparatus Renal cancer:8.76e-4 (favourable) Expressed in all Tissue enriched 6 testis: 538.0 fallopian tube: 84.2 FAM64A CATS, FLJ10156, FLJ10491, RCS1 ENSG00000129195 Family with sequence similarity 64, member A 17 6444415-6451469 Predicted intracellular proteins Evidence at protein level HPA043783, HPA049934 Uncertain Validated Nucleus
Nucleoli
Cytosol Mixed Mixed spleen: 6.6 FAM98C FLJ44669 ENSG00000130244 Family with sequence similarity 98, member C 19 38403135-38409088 Predicted intracellular proteins Evidence at protein level HPA040930, HPA041730 Approved Approved Nucleus
Nucleoli
Cytosol Ovarian cancer:8.51e-5 (unfavourable), Urothelial cancer:5.53e-4 (favourable) Expressed in all Mixed small intestine: 15.5 FANCG FAG, XRCC9 ENSG00000221829 Fanconi anemia, complementation group G 9 35073835-35080016 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level CAB008105, HPA045335 Approved Supported Nucleoli
Plasma membrane
Cytosol Renal cancer:2.38e-7 (unfavourable), Liver cancer:2.02e-4 (unfavourable) Expressed in all Mixed fallopian tube: 8.5 FAU asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30 ENSG00000149806 Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 11 65120628-65122473 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA059015 Supported Supported Nucleoli
Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 1268.2 FBXL2 FBL2, FBL3 ENSG00000153558 F-box and leucine-rich repeat protein 2 3 33277025-33403662 Predicted intracellular proteins Evidence at protein level HPA061783 Approved Nucleus
Nucleoli
Plasma membrane Renal cancer:3.35e-4 (favourable) Mixed Mixed cerebral cortex: 5.8 FEZ2 ENSG00000171055 Fasciculation and elongation protein zeta 2 (zygin II) 2 36531805-36646087 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA035978 Uncertain Approved Nucleoli
Golgi apparatus
Cytosol Liver cancer:7.79e-6 (unfavourable) Expressed in all Expressed in all cerebral cortex: 78.9 FOXM1 FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident ENSG00000111206 Forkhead box M1 12 2857681-2877155 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017832, HPA029974 Uncertain Supported Nucleus
Nucleoli
Cytosol Renal cancer:0.00e+0 (unfavourable), Liver cancer:1.95e-6 (unfavourable), Pancreatic cancer:3.03e-5 (unfavourable), Lung cancer:2.92e-4 (unfavourable) Expressed in all Tissue enhanced testis: 39.5 bone marrow: 15.9 FPR1 FMLP, FPR ENSG00000171051 Formyl peptide receptor 1 19 51745172-51804110 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA046550, HPA061744 Approved Approved Nucleus
Nucleoli
Golgi apparatus Renal cancer:2.21e-4 (unfavourable) Expressed in all Tissue enhanced appendix: 181.6 bone marrow: 95.2 FRMD8 FKSG44, FLJ90369 ENSG00000126391 FERM domain containing 8 11 65386599-65413525 Predicted intracellular proteins Evidence at protein level HPA002861, HPA005506 Approved Approved Nucleus
Nucleoli
Cytosol Liver cancer:9.94e-5 (unfavourable) Expressed in all Expressed in all skin: 25.0 FXYD1 PLM ENSG00000266964 FXYD domain containing ion transport regulator 1 19 35138808-35143109 Predicted membrane proteins Evidence at protein level HPA026873 Approved Nucleus
Nucleoli
Cytosol Renal cancer:7.59e-8 (unfavourable), Glioma:9.67e-4 (unfavourable) Tissue enhanced Expressed in all skeletal muscle: 469.2 GCLC GCS, GLCL, GLCLC ENSG00000001084 Glutamate-cysteine ligase, catalytic subunit 6 53497341-53616970 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB009569, HPA036359, HPA036360 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:3.83e-6 (favourable), Thyroid cancer:8.24e-4 (unfavourable) Expressed in all Expressed in all fallopian tube: 81.9 GDE1 MIR16 ENSG00000006007 Glycerophosphodiester phosphodiesterase 1 16 19501689-19522145 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA074747 Approved Nucleus
Nucleoli
Vesicles Renal cancer:3.12e-5 (favourable), Liver cancer:7.52e-5 (unfavourable), Colorectal cancer:3.12e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 68.8 GEMIN2 SIP1 ENSG00000092208 Gem (nuclear organelle) associated protein 2 14 39114223-39136973 Predicted intracellular proteins Evidence at protein level CAB015426, HPA046570, HPA057114 Supported Supported Nucleus
Nucleoli
Nuclear bodies Liver cancer:3.88e-6 (unfavourable) Expressed in all Expressed in all testis: 17.4 GET4 C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35 ENSG00000239857 Golgi to ER traffic protein 4 7 876552-896436 Predicted intracellular proteins Evidence at protein level HPA019765 Uncertain Supported Nucleoplasm
Nucleoli
Cytosol Expressed in all Expressed in all testis: 49.8 GJC1 CX45, GJA7 ENSG00000182963 Gap junction protein, gamma 1, 45kDa 17 44798448-44830816 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA071788 Uncertain Nucleoli
Cell Junctions
Cytosol Renal cancer:3.55e-8 (unfavourable), Urothelial cancer:7.83e-4 (unfavourable) Expressed in all Tissue enhanced endometrium: 43.9;placenta: 50.9;smooth muscle: 48.2 seminal vesicle: 27.0 GLOD4 C17orf25, CGI-150, HC71 ENSG00000167699 Glyoxalase domain containing 4 17 757097-783390 Predicted intracellular proteins Evidence at protein level HPA021623, HPA023246, HPA023248 Supported Approved Nucleus
Nucleoli
Cytosol Renal cancer:2.18e-6 (favourable) Expressed in all Expressed in all duodenum: 83.4 GNAI1 ENSG00000127955 Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 7 80133955-80219402 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB022449, HPA042141 Approved Supported Nucleus
Nucleoli
Centrosome Melanoma:5.09e-4 (unfavourable), Stomach cancer:6.47e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 94.8 GNAI3 87U6 ENSG00000065135 Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 1 109548611-109618321 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB022099, HPA042141 Approved Supported Nucleus
Nucleoli
Centrosome Liver cancer:5.30e-6 (unfavourable), Colorectal cancer:1.62e-4 (favourable), Renal cancer:4.34e-4 (unfavourable), Ovarian cancer:4.59e-4 (favourable) Expressed in all Mixed esophagus: 8.0 GNL3L FLJ10613 ENSG00000130119 Guanine nucleotide binding protein-like 3 (nucleolar)-like X 54530211-54561071 Predicted intracellular proteins Evidence at protein level HPA036314, HPA036315 Supported Supported Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all thyroid gland: 16.4 GPC2 cerebroglycan, DKFZp547M109, FLJ38962 ENSG00000213420 Glypican 2 7 100169606-100177372 Predicted secreted proteins Evidence at protein level CAB025423, HPA053945 Uncertain Uncertain Nucleus
Nucleoli
Golgi apparatus Urothelial cancer:9.94e-4 (favourable) Mixed Tissue enhanced skin: 5.7;testis: 10.1 cerebral cortex: 3.4 GPR137 C11orf4, GPR137A, TM7SF1L1 ENSG00000173264 G protein-coupled receptor 137 11 64270062-64289500 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA062871 Uncertain Approved Nucleus
Nucleoli
Actin filaments Liver cancer:5.34e-4 (unfavourable), Pancreatic cancer:6.18e-4 (favourable) Expressed in all Expressed in all testis: 147.8 GPR157 FLJ12132 ENSG00000180758 G protein-coupled receptor 157 1 9100305-9129170 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA028697 Uncertain Uncertain Nucleoli
Plasma membrane
Cell Junctions Expressed in all Mixed parathyroid gland: 23.9 GPRC5B RAIG-2 ENSG00000167191 G protein-coupled receptor, class C, group 5, member B 16 19856691-19886167 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015247 Approved Supported Nucleus
Nucleoli
Vesicles Colorectal cancer:9.27e-5 (unfavourable), Renal cancer:6.30e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 309.2 testis: 66.5 GRAMD1B KIAA1201 ENSG00000023171 GRAM domain containing 1B 11 123454398-123627774 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA008557 Approved Approved Nucleus
Nucleoli
Intermediate filaments Renal cancer:4.30e-7 (unfavourable) Mixed Tissue enhanced adrenal gland: 87.8 cerebral cortex: 39.0 GRAMD2 ENSG00000175318 GRAM domain containing 2 15 72159807-72197785 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA029435 Uncertain Approved Nucleoli
Nuclear speckles
Cytosol Thyroid cancer:7.01e-4 (unfavourable) Mixed Tissue enhanced epididymis: 45.7;placenta: 69.4 lung: 23.6 GSKIP C14orf129 ENSG00000100744 GSK3B interacting protein 14 96363452-96387288 Predicted intracellular proteins Evidence at protein level HPA043054, HPA046782 Approved Approved Nucleoli
Golgi apparatus
Vesicles Expressed in all Expressed in all small intestine: 63.2 GYG2 GN-2 ENSG00000056998 Glycogenin 2 X 2828788-2882818 Enzymes, Predicted intracellular proteins Evidence at protein level HPA005495, HPA064686 Approved Approved Nucleus
Nucleoli
Cytosol Pancreatic cancer:3.01e-5 (favourable) Expressed in all Tissue enriched 13 adipose tissue: 161.7 breast: 12.5 HEATR5B DKFZp686P15184, KIAA1414 ENSG00000008869 HEAT repeat containing 5B 2 36968383-37084342 Predicted intracellular proteins Evidence at protein level HPA042025, HPA055639 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all lymph node: 38.4 HELZ DHRC, HUMORF5, KIAA0054 ENSG00000198265 Helicase with zinc finger 17 67070438-67245989 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA028276 Approved Approved Nucleoli
Plasma membrane
Actin filaments Expressed in all Expressed in all parathyroid gland: 32.3 HINT3 FLJ33126 ENSG00000111911 Histidine triad nucleotide binding protein 3 6 125956781-125980244 Predicted intracellular proteins Evidence at protein level HPA027914 Approved Supported Nucleoli
Mitochondria
Cytosol Renal cancer:1.05e-6 (favourable), Breast cancer:4.99e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 49.8 HJURP DKFZp762E1312, FAKTS, hFLEG1, URLC9 ENSG00000123485 Holliday junction recognition protein 2 233833416-233854566 Predicted intracellular proteins Evidence at protein level HPA008436, HPA027261 Uncertain Validated Nucleus
Nucleoli
Cytosol Liver cancer:3.37e-5 (unfavourable), Pancreatic cancer:7.72e-5 (unfavourable), Lung cancer:2.46e-4 (unfavourable), Melanoma:6.49e-4 (unfavourable) Mixed Tissue enhanced bone marrow: 28.7;testis: 19.9 lymph node: 15.3 HN1 ARM2, HN1A ENSG00000189159 Hematological and neurological expressed 1 17 75135248-75168281 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA059729 Approved Supported Nucleus
Nuclear membrane
Nucleoli Liver cancer:1.58e-7 (unfavourable), Renal cancer:1.77e-7 (unfavourable), Ovarian cancer:4.91e-4 (favourable) Expressed in all Expressed in all testis: 421.3 IFI16 IFNGIP1, PYHIN2 ENSG00000163565 Interferon, gamma-inducible protein 16 1 158999968-159055155 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA002134, CAB016293 Supported Supported Nucleus
Nucleoli
Cytosol Renal cancer:1.11e-16 (unfavourable) Expressed in all Expressed in all lymph node: 165.5 IKZF1 hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1 ENSG00000185811 IKAROS family zinc finger 1 (Ikaros) 7 50304124-50405101 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level CAB009247, HPA035221, HPA035222 Supported Approved Nucleoplasm
Nucleoli
Vesicles Cervical cancer:2.02e-4 (favourable), Breast cancer:4.28e-4 (favourable), Head and neck cancer:8.63e-4 (favourable) Expressed in all Tissue enhanced lymph node: 84.0;tonsil: 58.0 appendix: 55.9 ILF3 DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1 ENSG00000129351 Interleukin enhancer binding factor 3, 90kDa 19 10654261-10692417 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA001897 Supported Supported Nucleoplasm
Nucleoli
Mitochondria Melanoma:1.57e-4 (unfavourable), Renal cancer:9.65e-4 (unfavourable) Expressed in all Expressed in all testis: 149.2 IRAK4 NY-REN-64 ENSG00000198001 Interleukin-1 receptor-associated kinase 4 12 43758944-43789543 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level CAB016685, CAB022077 Uncertain Approved Nucleoli
Microtubules
Cytosol Endometrial cancer:3.46e-5 (favourable), Urothelial cancer:4.42e-5 (favourable) Expressed in all Mixed lymph node: 20.6 JRK jerky, JH8 ENSG00000234616 Jrk helix-turn-helix protein 8 142657460-142681968 Predicted intracellular proteins Evidence at transcript level HPA052675 Approved Nucleus
Nucleoli
Nuclear bodies Expressed in all Mixed testis: 10.9 KAT6A MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220 ENSG00000083168 K(lysine) acetyltransferase 6A 8 41929479-42051990 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017023, HPA063266, HPA065052 Supported Approved Nucleoli
Nuclear speckles
Cytosol Expressed in all Expressed in all parathyroid gland: 33.9 KCNB2 Kv2.2 ENSG00000182674 Potassium channel, voltage gated Shab related subfamily B, member 2 8 72537391-72938349 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA065970 Approved Nucleoli
Plasma membrane
Midbody Not detected Tissue enhanced cerebral cortex: 3.2;spleen: 3.4 fallopian tube,testis: 0.7 KIAA1551 C12orf35, FLJ10652, FLJ20696, UTA2-1 ENSG00000174718 KIAA1551 12 31959370-31993107 Predicted intracellular proteins Evidence at protein level HPA013816, HPA015622 Approved Supported Nucleoli
Intermediate filaments
Cytosol Renal cancer:5.04e-9 (unfavourable) Expressed in all Expressed in all ovary: 90.6 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 20 38210488-38260772 Predicted intracellular proteins Evidence at protein level HPA051064 Approved Approved Nucleoli
Golgi apparatus
Vesicles Tissue enhanced Mixed cerebral cortex: 33.7 KIF2A HK2, KIF2 ENSG00000068796 Kinesin heavy chain member 2A 5 62306162-62537249 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA004715, HPA004716 Approved Validated Nucleus
Nucleoli
Centrosome Liver cancer:3.17e-6 (unfavourable), Renal cancer:3.81e-5 (unfavourable), Colorectal cancer:1.70e-4 (favourable), Head and neck cancer:5.45e-4 (favourable) Expressed in all Expressed in all testis: 91.5 KIF2B ENSG00000141200 Kinesin family member 2B 17 53822901-53825213 Predicted intracellular proteins Evidence at protein level HPA023081, HPA023103, HPA024795 Uncertain Approved Nucleus
Nucleoli
Microtubules Not detected Tissue enriched 1324 testis: 132.4 all non-specific tissues: 0.0 KIF3B FLA8, KIAA0359, KLP-11 ENSG00000101350 Kinesin family member 3B 20 32277664-32335011 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA007119 Approved Uncertain Nucleoplasm
Nucleoli
Golgi apparatus Renal cancer:1.44e-12 (favourable) Expressed in all Expressed in all parathyroid gland: 79.3 KIF5C ENSG00000168280 Kinesin family member 5C 2 148875250-149026759 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA035210 Approved Approved Nucleoli
Plasma membrane
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 205.9 prostate: 42.3 LHX8 Lhx7 ENSG00000162624 LIM homeobox 8 1 75128434-75161533 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071806 Approved Nucleus
Nucleoli
Cytosol Not detected Tissue enhanced placenta: 1.8;testis: 1.4;tonsil: 1.6 gallbladder,urinary bladder: 1.0 LIN28B CSDD2, FLJ16517 ENSG00000187772 Lin-28 homolog B (C. elegans) 6 104957048-105083332 Predicted intracellular proteins Evidence at protein level HPA036630, HPA061745 Supported Supported Nucleus
Nucleoli
Cytosol Tissue enriched Tissue enriched 13 placenta: 67.2 testis: 5.3 LRCH1 CHDC1, KIAA1016 ENSG00000136141 Leucine-rich repeats and calponin homology (CH) domain containing 1 13 46553168-46753040 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA021536 Uncertain Approved Nucleoli
Actin filaments
Cytosol Renal cancer:1.04e-4 (favourable), Ovarian cancer:5.75e-4 (unfavourable), Cervical cancer:6.24e-4 (unfavourable), Lung cancer:6.67e-4 (unfavourable) Expressed in all Expressed in all endometrium: 26.6 LRP4 CLSS, LRP-4, MEGF7, SOST2 ENSG00000134569 Low density lipoprotein receptor-related protein 4 11 46856868-46918642 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA011934, HPA012300 Approved Uncertain Nucleus
Nucleoli
Mitochondria Expressed in all Tissue enhanced cerebral cortex: 35.5;skin: 38.0 parathyroid gland: 12.9 LRRN4 C20orf75, dJ1056H1.1, NLRR4 ENSG00000125872 Leucine rich repeat neuronal 4 20 6040778-6054049 Predicted membrane proteins Evidence at protein level HPA075974 Approved Nucleus
Nucleoli
Cytosol Group enriched Tissue enriched 11 lung: 13.6 fallopian tube: 1.3 MACROD2 C20orf133, dJ631M13.5 ENSG00000172264 MACRO domain containing 2 20 13995369-16053197 Predicted intracellular proteins Evidence at protein level HPA049076 Approved Supported Nucleus
Nucleoli
Centrosome Mixed Mixed lung: 16.3 MAD2L1BP CMT2, dJ261G23.1, KIAA0110 ENSG00000124688 MAD2L1 binding protein 6 43629540-43640952 Predicted intracellular proteins Evidence at protein level HPA028729 Supported Nucleus
Nuclear membrane
Nucleoli Expressed in all Expressed in all bone marrow: 32.6 MAF1 DKFZp586G1123 ENSG00000179632 MAF1 homolog, negative regulator of RNA polymerase III 8 144104499-144107611 Predicted intracellular proteins Evidence at protein level HPA024821, HPA058548 Uncertain Supported Nucleus
Nucleoli
Vesicles Liver cancer:7.09e-4 (unfavourable) Expressed in all Expressed in all skeletal muscle: 142.6 MAGEC2 CT10, MAGE-C2, MAGEE1 ENSG00000046774 Melanoma antigen family C2 X 142202345-142205290 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA062230 Supported Supported Nucleus
Nucleoli
Cytosol Tissue enhanced Tissue enriched 368 testis: 36.7 all non-specific tissues: 0.0 MAGED2 11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386 ENSG00000102316 Melanoma antigen family D2 X 54807599-54816012 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA031572, HPA031573 Supported Validated Nucleus
Nucleoli
Cytosol Pancreatic cancer:2.82e-4 (favourable), Ovarian cancer:2.88e-4 (favourable), Stomach cancer:9.43e-4 (unfavourable) Expressed in all Expressed in all prostate: 313.4 MAPK13 p38delta, PRKM13, SAPK4 ENSG00000156711 Mitogen-activated protein kinase 13 6 36127809-36144524 Enzymes, Predicted intracellular proteins Evidence at protein level HPA007667, CAB025854 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:9.00e-4 (favourable) Expressed in all Mixed skin: 93.9 MARCKS 80K-L, MACS, PKCSL ENSG00000277443 Myristoylated alanine-rich protein kinase C substrate 6 113857362-113863471 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB022062, HPA051913, HPA054820 Uncertain Approved Nucleoli
Plasma membrane
Cytosol Liver cancer:2.78e-8 (unfavourable), Renal cancer:4.85e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 219.4 MBIP ENSG00000151332 MAP3K12 binding inhibitory protein 1 14 36298558-36320676 Predicted intracellular proteins Evidence at protein level HPA003388 Supported Supported Nucleus
Nucleoli
Cytosol Ovarian cancer:1.14e-4 (favourable), Renal cancer:1.25e-4 (favourable), Lung cancer:1.52e-4 (favourable) Expressed in all Expressed in all thyroid gland: 135.8 MED21 SRB7, SURB7 ENSG00000152944 Mediator complex subunit 21 12 27022546-27066343 Predicted intracellular proteins Evidence at protein level HPA017177 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:3.74e-8 (favourable) Expressed in all Expressed in all testis: 69.0 MED27 CRSP34, CRSP8, MED3, TRAP37 ENSG00000160563 Mediator complex subunit 27 9 131860107-132079908 Predicted intracellular proteins Evidence at protein level HPA007002 Approved Supported Nucleus
Nucleoli
Cytosol Cervical cancer:1.59e-4 (favourable) Expressed in all Expressed in all testis: 29.1 MKI67 MIB-, PPP1R105 ENSG00000148773 Marker of proliferation Ki-67 10 128096659-128126385 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB000058, HPA000451, HPA001164, CAB068198 Supported Validated Nucleus
Nucleoli
Nuclear bodies Renal cancer:0.00e+0 (unfavourable), Liver cancer:3.61e-6 (unfavourable), Pancreatic cancer:9.47e-5 (unfavourable) Expressed in all Tissue enhanced bone marrow: 28.9 lymph node: 18.1 MKNK2 GPRK7, MNK2 ENSG00000099875 MAP kinase interacting serine/threonine kinase 2 19 2037465-2051244 Enzymes, Predicted intracellular proteins Evidence at protein level HPA021875, CAB037253, HPA053989 Supported Supported Nucleus
Nucleoli
Nuclear bodies Endometrial cancer:4.86e-5 (favourable), Stomach cancer:4.01e-4 (favourable) Expressed in all Expressed in all skeletal muscle: 174.4 MNX1 HB9, HLXB9, HOXHB9, SCRA1 ENSG00000130675 Motor neuron and pancreas homeobox 1 7 156994051-157010651 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071717 Approved Nucleus
Nucleoli
Cytosol Mixed Tissue enhanced duodenum: 7.5;small intestine: 6.8 colon: 3.8 MOB1A C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B ENSG00000114978 MOB kinase activator 1A 2 74152528-74178898 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA047088, HPA071690 Supported Approved Nucleus
Nucleoli
Cytosol Liver cancer:3.34e-4 (unfavourable) Expressed in all Expressed in all lymph node: 109.0 MOB1B MOB4A, MOBKL1A ENSG00000173542 MOB kinase activator 1B 4 70902326-71022449 Predicted intracellular proteins Evidence at protein level HPA047088, HPA071690 Supported Approved Nucleus
Nucleoli
Cytosol Liver cancer:4.92e-4 (unfavourable) Expressed in all Expressed in all kidney: 24.1 MOB2 HCCA2 ENSG00000182208 MOB kinase activator 2 11 1469457-1501247 Predicted intracellular proteins Evidence at protein level HPA046313 Uncertain Supported Nucleus
Nucleoli
Cytosol Renal cancer:2.02e-4 (favourable), Glioma:7.86e-4 (unfavourable) Expressed in all Expressed in all seminal vesicle: 35.2 MPP1 DXS552E, PEMP ENSG00000130830 Membrane protein, palmitoylated 1, 55kDa X 154778684-154821007 Predicted intracellular proteins Evidence at protein level HPA000167 Approved Nucleoli
Nuclear speckles
Cytosol Renal cancer:4.60e-6 (favourable) Expressed in all Expressed in all placenta: 118.7 MPPED2 239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638 ENSG00000066382 Metallophosphoesterase domain containing 2 11 30384493-30586872 Predicted intracellular proteins Evidence at protein level HPA062575 Approved Nucleoli
Vesicles
Mitochondria Mixed Tissue enhanced cervix, uterine: 38.4;thyroid gland: 43.4 prostate: 21.5 MRTO4 C1orf33, dJ657E11.4, MRT4 ENSG00000053372 MRT4 homolog, ribosome maturation factor 1 19251539-19260128 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA026446 Approved Approved Nucleus
Nuclear membrane
Nucleoli Liver cancer:1.56e-8 (unfavourable), Renal cancer:4.11e-8 (unfavourable) Expressed in all Expressed in all fallopian tube: 26.0 MYBL1 A-myb, AMYB ENSG00000185697 V-myb avian myeloblastosis viral oncogene homolog-like 1 8 66562175-66614247 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008791, CAB017780 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:2.03e-8 (unfavourable) Mixed Tissue enhanced lymph node: 24.5;testis: 21.3 tonsil: 15.4 MYBPH ENSG00000133055 Myosin binding protein H 1 203167811-203175813 Predicted intracellular proteins Evidence at protein level HPA061383 Approved Nucleus
Nucleoli
Mitochondria Group enriched Tissue enhanced prostate: 4.2;skeletal muscle: 7.9 esophagus: 1.2 MYO10 KIAA0799 ENSG00000145555 Myosin X 5 16661914-16936276 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB015224, HPA024223 Supported Supported Nucleoli
Plasma membrane
Cytosol Renal cancer:2.75e-4 (favourable), Cervical cancer:4.35e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 68.5 MYRIP DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C ENSG00000170011 Myosin VIIA and Rab interacting protein 3 39808914-40260321 Predicted intracellular proteins Evidence at protein level HPA006433 Approved Nucleus
Nucleoli
Golgi apparatus Renal cancer:3.96e-8 (favourable) Mixed Tissue enhanced cerebral cortex: 20.7 spleen: 10.1 NBAS NAG ENSG00000151779 Neuroblastoma amplified sequence 2 15166909-15561330 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036817 Approved Approved Nuclear membrane
Nucleoli
Golgi apparatus Urothelial cancer:5.84e-5 (unfavourable), Liver cancer:1.10e-4 (unfavourable) Expressed in all Expressed in all testis: 37.4 NBEA BCL8B, FLJ10197, KIAA1544 ENSG00000172915 Neurobeachin 13 34942287-35673022 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039730, HPA040385 Approved Approved Nucleus
Nucleoli
Golgi apparatus Renal cancer:7.86e-8 (favourable) Mixed Tissue enhanced cerebral cortex: 30.4 prostate: 12.3 NCOA4 ARA70, DKFZp762E1112, ELE1, PTC3, RFG ENSG00000266412 Nuclear receptor coactivator 4 10 46005088-46030714 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level HPA051260, HPA065208 Uncertain Approved Nucleoli
Golgi apparatus
Cytosol Renal cancer:8.04e-6 (favourable), Glioma:2.88e-4 (favourable) Expressed in all Expressed in all duodenum: 253.9 NDP EVR2, norrin ENSG00000124479 Norrie disease (pseudoglioma) X 43948776-43973504 Disease related genes, Predicted secreted proteins Evidence at protein level HPA003095 Uncertain Approved Nucleus
Nucleoli
Vesicles Tissue enhanced Tissue enhanced ovary: 53.0 fallopian tube: 30.9 NGDN C14orf120, DKFZP564O092, LCP5, lpd-2, NGD ENSG00000129460 Neuroguidin, EIF4E binding protein 14 23469688-23509862 Predicted intracellular proteins Evidence at protein level HPA000944 Approved Approved Nucleus
Nucleoli
Mitochondria Expressed in all Expressed in all endometrium: 54.8 NIN ENSG00000100503 Ninein (GSK3B interacting protein) 14 50719763-50831121 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA005939, HPA070691 Supported Validated Nucleus
Nucleoli
Centrosome Expressed in all Mixed lymph node: 48.1 NLK ENSG00000087095 Nemo-like kinase 17 28041737-28196381 Enzymes, Predicted intracellular proteins Evidence at protein level HPA018192, HPA056511 Approved Supported Nucleus
Nucleoli
Cell Junctions Expressed in all Expressed in all cerebral cortex: 52.5 NOL12 MGC3731, Nop25, RRP17 ENSG00000273899 Nucleolar protein 12 22 37681673-37693478 Predicted intracellular proteins Evidence at protein level HPA003547 Uncertain Approved Nucleus
Nucleoli
Vesicles Renal cancer:2.56e-6 (unfavourable), Cervical cancer:6.80e-5 (favourable), Urothelial cancer:3.24e-4 (favourable), Lung cancer:9.41e-4 (favourable) Expressed in all Expressed in all adrenal gland: 25.2 NOL6 bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22 ENSG00000165271 Nucleolar protein 6 (RNA-associated) 9 33461441-33473930 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA055891, HPA061002 Supported Validated Nucleus
Nucleoli
Mitochondria Liver cancer:4.83e-5 (unfavourable), Thyroid cancer:9.49e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 28.1 NOL7 C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1 ENSG00000225921 Nucleolar protein 7, 27kDa 6 13615327-13632739 Predicted intracellular proteins Evidence at protein level HPA029185, HPA049693 Supported Validated Nucleus
Nucleoli
Mitochondria Ovarian cancer:3.64e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 91.5 NOP9 C14orf21 ENSG00000196943 NOP9 nucleolar protein 14 24299862-24309124 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA000850 Approved Nucleus
Nucleoli
Cytosol Renal cancer:9.39e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 28.8 NPM3 ENSG00000107833 Nucleophosmin/nucleoplasmin 3 10 101781325-101783413 Predicted intracellular proteins Evidence at protein level HPA036295, HPA036296 Approved Approved Nucleoli
Actin filaments
Cytosol Head and neck cancer:1.42e-4 (unfavourable) Expressed in all Expressed in all smooth muscle: 28.4 NPR1 ANPa, ANPRA, GUCY2A, NPRA ENSG00000169418 Natriuretic peptide receptor 1 1 153678637-153693992 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level HPA031087 Approved Nucleus
Nucleoli
Plasma membrane Pancreatic cancer:2.49e-4 (favourable), Endometrial cancer:3.97e-4 (unfavourable) Expressed in all Tissue enhanced adipose tissue: 71.8;fallopian tube: 57.6 placenta: 25.2 NUDT19 RP2 ENSG00000213965 Nudix (nucleoside diphosphate linked moiety X)-type motif 19 19 32691961-32713796 Predicted secreted proteins Evidence at protein level HPA042761 Uncertain Nucleus
Nucleoli
Cytosol Urothelial cancer:1.35e-4 (favourable) Expressed in all Expressed in all prostate: 12.4 OLFM1 AMY, NOE1, NOELIN, OlfA ENSG00000130558 Olfactomedin 1 9 135075243-135121179 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA057444 Uncertain Approved Nucleus
Nucleoli
Cytosol Cervical cancer:7.14e-4 (favourable), Glioma:9.38e-4 (unfavourable) Expressed in all Tissue enriched 9 cerebral cortex: 732.4 epididymis: 85.0 OSCP1 C1orf102, NOR1 ENSG00000116885 Organic solute carrier partner 1 1 36415827-36450451 Predicted intracellular proteins, Transporters Evidence at protein level HPA028436, HPA052655 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Renal cancer:2.18e-6 (favourable), Endometrial cancer:6.88e-4 (favourable) Expressed in all Expressed in all testis: 126.0 PAFAH1B2 ENSG00000168092 Platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) 11 117144267-117176894 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level HPA051836 Approved Supported Nucleoli
Plasma membrane
Cytosol Pancreatic cancer:7.79e-5 (unfavourable), Lung cancer:3.07e-4 (unfavourable), Ovarian cancer:4.25e-4 (favourable), Liver cancer:9.44e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 68.4 PBDC1 CXorf26, MGC874 ENSG00000102390 Polysaccharide biosynthesis domain containing 1 X 76172936-76178204 Predicted intracellular proteins Evidence at protein level HPA003155 Uncertain Approved Nucleus
Nucleoli
Cytosol Thyroid cancer:8.57e-4 (favourable) Expressed in all Expressed in all prostate: 41.0 PCDH1 pc42 ENSG00000156453 Protocadherin 1 5 141853111-141879246 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA047720, HPA050538 Approved Approved Nucleus
Nucleoli
Cell Junctions Liver cancer:4.96e-5 (unfavourable), Renal cancer:7.55e-5 (favourable), Pancreatic cancer:3.61e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 40.4 PCDHAC1 ENSG00000248383 Protocadherin alpha subfamily C, 1 5 140926369-141012344 Predicted membrane proteins Evidence at transcript level HPA052775 Approved Nucleus
Nucleoli
Vesicles Not detected Tissue enriched 26 parathyroid gland: 68.4 cerebral cortex: 2.6 PCP4 PEP-19 ENSG00000183036 Purkinje cell protein 4 21 39867317-39929397 Predicted intracellular proteins Evidence at protein level HPA005792 Supported Supported Approved Nucleus
Nucleoli
Cytosol Renal cancer:1.85e-7 (favourable), Cervical cancer:9.76e-4 (favourable) Mixed Tissue enhanced prostate: 412.7;seminal vesicle: 1194.8 epididymis: 295.1 PCSK7 LPC, PC7, PC8, SPC7 ENSG00000160613 Proprotein convertase subtilisin/kexin type 7 11 117204337-117232525 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA043181, HPA052957 Uncertain Nucleus
Nuclear membrane
Nucleoli Expressed in all Expressed in all smooth muscle: 305.0 PDGFRL PRLTS ENSG00000104213 Platelet-derived growth factor receptor-like 8 17576433-17644071 Disease related genes, Predicted secreted proteins Evidence at protein level HPA052801 Approved Nucleus
Nucleoli
Golgi apparatus Renal cancer:0.00e+0 (unfavourable) Expressed in all Mixed breast: 48.9 PELI1 ENSG00000197329 Pellino E3 ubiquitin protein ligase 1 2 64092652-64144454 Predicted intracellular proteins Evidence at protein level HPA053182 Uncertain Approved Nucleus
Nucleoli
Intermediate filaments Renal cancer:5.67e-6 (unfavourable), Endometrial cancer:5.33e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 144.1 PELI2 ENSG00000139946 Pellino E3 ubiquitin protein ligase family member 2 14 56117814-56301526 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA053182 Uncertain Approved Nucleus
Nucleoli
Intermediate filaments Renal cancer:1.53e-6 (favourable) Mixed Mixed testis: 19.0 PELI3 MGC35521 ENSG00000174516 Pellino E3 ubiquitin protein ligase family member 3 11 66466327-66477337 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB033750, HPA038875, HPA062281 Uncertain Approved Nucleus
Nucleoli
Vesicles Renal cancer:8.19e-4 (favourable) Expressed in all Mixed parathyroid gland: 24.1 PFDN1 PFD1 ENSG00000113068 Prefoldin subunit 1 5 140245039-140303121 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA006499 Approved Approved Nucleoli
Plasma membrane
Cytosol Liver cancer:8.81e-5 (unfavourable) Expressed in all Expressed in all cerebral cortex: 106.6 PGAM2 PGAM-M ENSG00000164708 Phosphoglycerate mutase 2 (muscle) 7 44062727-44065587 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA043801, HPA049237, HPA060173 Approved Uncertain Nucleus
Nucleoli
Cytosol Not detected Group enriched 8 heart muscle: 527.3;skeletal muscle: 1459.8 testis: 126.1 PHF2 CENP-35, JHDM1E, KIAA0662 ENSG00000197724 PHD finger protein 2 9 93576407-93679587 Predicted intracellular proteins Evidence at protein level HPA010831 Approved Supported Nucleus
Nucleoli
Cytosol Renal cancer:1.12e-5 (favourable), Colorectal cancer:9.34e-4 (unfavourable) Expressed in all Expressed in all endometrium: 30.6 PIGR ENSG00000162896 Polymeric immunoglobulin receptor 1 206928518-206946466 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA006154, CAB009454, HPA012012 Supported Uncertain Nucleus
Nucleoli
Cytosol Breast cancer:1.22e-5 (favourable), Renal cancer:5.08e-5 (favourable), Endometrial cancer:2.57e-4 (favourable) Tissue enhanced Tissue enhanced colon: 1721.7;duodenum: 2732.8 rectum: 1357.3 PIK3CB PIK3C1 ENSG00000051382 Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 3 138652699-138834938 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level CAB031938, HPA064207 Approved Supported Nucleoplasm
Nucleoli
Midbody Pancreatic cancer:3.99e-5 (unfavourable), Liver cancer:6.42e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 88.7 PKMYT1 MYT1, PPP1R126 ENSG00000127564 Protein kinase, membrane associated tyrosine/threonine 1 16 2968024-2980539 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA068860 Supported Nucleus
Nucleoli
Golgi apparatus Lung cancer:3.37e-4 (unfavourable), Liver cancer:8.33e-4 (unfavourable) Mixed Tissue enhanced bone marrow: 17.0;testis: 28.3 lymph node: 9.8 PNPLA3 adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon ENSG00000100344 Patatin-like phospholipase domain containing 3 22 43923739-43964488 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA058058 Approved Approved Nucleoli
Mitochondria
Cytosol Tissue enhanced Tissue enhanced liver: 16.2 kidney: 4.7 POLR2K RPB10alpha ENSG00000147669 Polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa 8 100150584-100154002 Predicted intracellular proteins, RNA polymerase related proteins Evidence at protein level HPA063185 Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all thyroid gland: 98.0 PPDPF C20orf149, dJ697K14.9, exdpf ENSG00000125534 Pancreatic progenitor cell differentiation and proliferation factor 20 63520724-63522206 Predicted intracellular proteins Evidence at protein level HPA040929 Approved Nucleoplasm
Nucleoli
Microtubules Renal cancer:3.91e-4 (favourable) Expressed in all Expressed in all stomach: 213.7 PPID CYP-40 ENSG00000171497 Peptidylprolyl isomerase D 4 158709134-158723396 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA019520, HPA019692 Approved Supported Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all liver: 71.3 PPP1R1C Inhibitor-1-like ENSG00000150722 Protein phosphatase 1, regulatory (inhibitor) subunit 1C 2 181954241-182131398 Predicted intracellular proteins Evidence at protein level HPA055043 Approved Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enriched 9 heart muscle: 13.0 prostate: 1.5 PPP1R3D PPP1R6 ENSG00000132825 Protein phosphatase 1, regulatory subunit 3D 20 59936668-59940297 Predicted intracellular proteins Evidence at protein level HPA041146 Approved Approved Nucleoli
Vesicles
Mitochondria Stomach cancer:9.14e-4 (favourable) Expressed in all Mixed parathyroid gland: 10.9 PRDM5 PFM2 ENSG00000138738 PR domain containing 5 4 120684919-120922870 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051406 Supported Supported Nucleus
Nucleoli
Nuclear bodies Mixed Mixed parathyroid gland: 20.6 PRIMA1 PRIMA ENSG00000175785 Proline rich membrane anchor 1 14 93718298-93788481 Predicted membrane proteins Evidence at protein level HPA046671, HPA060047 Approved Approved Nucleoli
Plasma membrane
Cytosol Renal cancer:2.62e-7 (unfavourable), Endometrial cancer:6.99e-5 (unfavourable) Mixed Mixed smooth muscle: 11.5 PRR19 MGC70924 ENSG00000188368 Proline rich 19 19 42302098-42310821 Predicted intracellular proteins Evidence at protein level HPA070350 Approved Nucleus
Nucleoli
Nuclear bodies Mixed Tissue enriched 10 testis: 22.5 cerebral cortex: 2.1 PRRG2 PRGP2 ENSG00000126460 Proline rich Gla (G-carboxyglutamic acid) 2 19 49580646-49591015 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA010702 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:3.82e-9 (favourable) Expressed in all Mixed parathyroid gland: 28.8 PSTK C10orf89, MGC35392 ENSG00000179988 Phosphoseryl-tRNA kinase 10 122954381-122997513 Enzymes, Predicted intracellular proteins Evidence at protein level HPA037780, HPA037781 Approved Approved Nucleoli
Nuclear bodies
Actin filaments Mixed Mixed testis: 5.6 PURG PURG-A, PURG-B ENSG00000172733 Purine-rich element binding protein G 8 30995802-31033715 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047746 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 6.6;testis: 4.8 endometrium: 2.6 PVALB D22S749 ENSG00000100362 Parvalbumin 22 36800684-36819479 Predicted intracellular proteins Evidence at protein level CAB002515, HPA048536 Supported Approved Nucleoplasm
Nucleoli
Cell Junctions Group enriched Tissue enriched 12 parathyroid gland: 536.6 kidney: 43.1 PYCARD ASC, CARD5, TMS-1 ENSG00000103490 PYD and CARD domain containing 16 31201485-31203450 Predicted intracellular proteins Evidence at protein level CAB006853, CAB015948, HPA049074, HPA054496 Supported Supported Nucleus
Nucleoli
Cytosol Renal cancer:6.09e-7 (unfavourable) Expressed in all Mixed duodenum: 52.9 RAC1 p21-Rac1, Rac-1, TC-25 ENSG00000136238 Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) 7 6374523-6403977 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level CAB035994, HPA047820 Approved Approved Nucleus
Nucleoli
Cytosol Liver cancer:1.74e-5 (unfavourable), Pancreatic cancer:4.57e-5 (unfavourable), Renal cancer:2.11e-4 (unfavourable), Lung cancer:4.59e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 282.4 RAD51 BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA ENSG00000051180 RAD51 recombinase 15 40694774-40732339 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level CAB010381, HPA039310 Approved Validated Nucleoli
Mitochondria
Cytosol Breast cancer:7.94e-4 (unfavourable), Liver cancer:9.33e-4 (unfavourable) Expressed in all Tissue enhanced testis: 45.1 lymph node,tonsil: 13.2 RASSF4 AD037, MGC44914 ENSG00000107551 Ras association (RalGDS/AF-6) domain family member 4 10 44959407-44995891 Predicted intracellular proteins Evidence at protein level HPA038834 Approved Approved Nucleus
Nucleoli
Cell Junctions Expressed in all Expressed in all cerebral cortex: 71.6 RBL2 p130, Rb2 ENSG00000103479 Retinoblastoma-like 2 16 53433977-53491649 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB016547, HPA019703 Supported Approved Nucleus
Nucleoli
Cytosol Renal cancer:3.57e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 158.3 REXO2 CGI-114, DKFZP566E144, SFN ENSG00000076043 RNA exonuclease 2 11 114439386-114450279 Predicted intracellular proteins Evidence at protein level HPA038450, HPA038451 Supported Supported Nucleoli
Focal adhesion sites
Mitochondria Colorectal cancer:6.51e-4 (favourable), Urothelial cancer:6.70e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 254.4 RHOJ ARHJ, FLJ14445, RASL7B, TCL ENSG00000126785 Ras homolog family member J 14 63204114-63293219 Predicted intracellular proteins Evidence at protein level HPA003050 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Renal cancer:1.31e-4 (unfavourable) Expressed in all Mixed endometrium: 47.9 RIN2 RASSF4 ENSG00000132669 Ras and Rab interactor 2 20 19886521-20002457 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA034641 Approved Approved Nucleoli
Golgi apparatus
Cytosol Renal cancer:8.34e-6 (favourable) Expressed in all Expressed in all gallbladder: 29.0 RIOK1 AD034, bA288G3.1, FLJ30006, RRP10 ENSG00000124784 RIO kinase 1 6 7389496-7418037 Enzymes, Predicted intracellular proteins Evidence at protein level HPA017866, HPA051446 Supported Approved Nucleoli
Nuclear speckles
Cytosol Liver cancer:3.41e-5 (unfavourable), Renal cancer:5.85e-5 (unfavourable), Melanoma:4.43e-4 (unfavourable) Expressed in all Expressed in all testis: 29.5 RNF125 FLJ20456 ENSG00000101695 Ring finger protein 125, E3 ubiquitin protein ligase 18 32018372-32073213 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA041514 Uncertain Uncertain Nucleoli
Golgi apparatus
Cytosol Renal cancer:4.06e-4 (unfavourable) Expressed in all Mixed small intestine: 11.8 RP11-195F19.5 ENSG00000187186 9 34664163-34666112 Predicted intracellular proteins Evidence at protein level HPA069617 Supported Approved Nucleoli
Endoplasmic reticulum
Vesicles Glioma:5.81e-5 (unfavourable) Mixed Tissue enriched 5 testis: 139.6 cerebral cortex: 25.8 RPL10A Csa-19, L10A, NEDD6 ENSG00000198755 Ribosomal protein L10a 6 35468408-35470785 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA053803 Approved Supported Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:3.77e-4 (unfavourable) Expressed in all Expressed in all ovary: 3913.5 RPL13 BBC1, D16S444E, L13 ENSG00000167526 Ribosomal protein L13 16 89560657-89566828 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA051702 Approved Validated Nucleoli
Endoplasmic reticulum
Cytosol Endometrial cancer:6.26e-4 (favourable), Renal cancer:6.64e-4 (unfavourable) Expressed in all Expressed in all ovary: 3867.8 RPL18 L18 ENSG00000063177 Ribosomal protein L18 19 48615328-48619536 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA046572 Approved Validated Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:1.21e-4 (unfavourable) Expressed in all Expressed in all ovary: 2568.3 RPL19 DKFZp779D216, FLJ27452, L19, MGC71997 ENSG00000108298 Ribosomal protein L19 17 39200283-39204727 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA043014, HPA051987 Approved Supported Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:6.87e-5 (unfavourable) Expressed in all Expressed in all ovary: 4342.3 RPL26 L26 ENSG00000161970 Ribosomal protein L26 17 8377520-8383213 Disease related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA030449, CAB037301 Approved Supported Nucleoli
Endoplasmic reticulum
Cytosol Expressed in all Expressed in all breast: 5169.8 RPL26L1 RPL26P1 ENSG00000037241 Ribosomal protein L26-like 1 5 172958729-172969771 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA030449 Approved Supported Nucleoli
Endoplasmic reticulum
Cytosol Head and neck cancer:2.49e-4 (unfavourable) Expressed in all Expressed in all testis: 124.7 RPL29 HIP, HUMRPL29, L29, RPL29P10 ENSG00000162244 Ribosomal protein L29 3 51993600-51995942 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA069064 Approved Validated Nucleoli
Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 2735.7 RPL34 L34 ENSG00000109475 Ribosomal protein L34 4 108620566-108630412 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA035139 Uncertain Supported Nucleoli
Endoplasmic reticulum
Cytosol Endometrial cancer:2.76e-5 (favourable) Expressed in all Expressed in all breast: 4590.2 RPL7 humL7-1, L7 ENSG00000147604 Ribosomal protein L7 8 73290267-73295789 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA058373 Approved Approved Nucleoli
Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 5517.3 RPL8 L8 ENSG00000161016 Ribosomal protein L8 8 144789765-144792587 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA045095, HPA050165 Supported Validated Nucleoli
Endoplasmic reticulum
Cytosol Liver cancer:7.22e-4 (unfavourable) Expressed in all Expressed in all ovary: 954.9 RPL9 L9 ENSG00000163682 Ribosomal protein L9 4 39454124-39458948 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA003372 Approved Approved Supported Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:7.34e-4 (unfavourable) Expressed in all Expressed in all epididymis: 2666.1 RPS11 S11 ENSG00000142534 Ribosomal protein S11 19 49496365-49499689 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA049719 Uncertain Supported Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:3.50e-7 (unfavourable) Expressed in all Expressed in all ovary: 6646.8 RPS17 MGC72007, RPS17L, RPS17L1, RPS17L2, S17 ENSG00000182774 Ribosomal protein S17 15 82536753-82540564 Disease related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA055060 Approved Supported Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:1.78e-4 (unfavourable) Expressed in all Expressed in all ovary: 1569.8 RPS19BP1 FLJ21770, MGC52010 ENSG00000187051 Ribosomal protein S19 binding protein 1 22 39529093-39532855 Predicted intracellular proteins Evidence at protein level HPA042874 Uncertain Supported Nucleus
Nucleoli
Cytosol Liver cancer:3.71e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 57.5 RPS26 S26 ENSG00000197728 Ribosomal protein S26 12 56041853-56044675 Disease related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA043961, HPA055803 Uncertain Validated Nucleoli
Endoplasmic reticulum
Cytosol Expressed in all Expressed in all thyroid gland: 822.8 RPS27 MPS-1, MPS1, S27 ENSG00000177954 Ribosomal protein S27 1 153990759-153992150 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA066851 Approved Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:4.86e-7 (unfavourable), Breast cancer:9.69e-4 (favourable) Expressed in all Expressed in all ovary: 11931.0 RPS27A S27A, Uba80, UBCEP80 ENSG00000143947 Ribosomal protein S27a 2 55231903-55235853 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level CAB033319, HPA041344, HPA049132, HPA054087 Supported Approved Nucleoli
Endoplasmic reticulum
Cytosol Renal cancer:2.60e-6 (unfavourable), Liver cancer:2.26e-4 (unfavourable) Expressed in all Expressed in all ovary: 3409.3 RPS27L ENSG00000185088 Ribosomal protein S27-like 15 63125872-63158021 Predicted intracellular proteins, Predicted secreted proteins, Ribosomal proteins Evidence at protein level HPA066851 Supported Nucleoli
Endoplasmic reticulum
Cytosol Endometrial cancer:9.08e-6 (favourable) Expressed in all Expressed in all adrenal gland: 223.3 RPS3A MFTL, S3A ENSG00000145425 Ribosomal protein S3A 4 151099573-151104652 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA047100, HPA053454 Approved Validated Nucleoli
Endoplasmic reticulum
Cytosol Liver cancer:6.56e-4 (unfavourable) Expressed in all Expressed in all ovary: 5244.0 RPS6KA3 CLS, HU-3, MRX19, RSK, RSK2 ENSG00000177189 Ribosomal protein S6 kinase, 90kDa, polypeptide 3 X 20149911-20267100 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA003221, CAB003853, CAB013520 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all parathyroid gland: 91.0 RPS6KA6 RSK4 ENSG00000072133 Ribosomal protein S6 kinase, 90kDa, polypeptide 6 X 84058346-84187907 Enzymes, Predicted intracellular proteins Evidence at protein level HPA002852, HPA003904 Uncertain Supported Nucleus
Nucleoli
Mitochondria Mixed Tissue enhanced parathyroid gland: 18.6;thyroid gland: 21.8 kidney: 8.8 RRP15 CGI-115, KIAA0507 ENSG00000067533 Ribosomal RNA processing 15 homolog 1 218285287-218337983 Predicted intracellular proteins Evidence at protein level HPA024639 Approved Approved Nucleus
Nucleoli
Mitochondria Liver cancer:4.26e-5 (unfavourable) Expressed in all Mixed parathyroid gland: 7.7 RRP7A CGI-96 ENSG00000189306 Ribosomal RNA processing 7 homolog A 22 42509968-42519802 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA001586, HPA046768 Approved Approved Nucleus
Nucleoli
Cell Junctions Liver cancer:1.21e-5 (unfavourable) Expressed in all Expressed in all epididymis: 49.0 RRP8 KIAA0409 ENSG00000132275 Ribosomal RNA processing 8, methyltransferase, homolog (yeast) 11 6595075-6603620 Predicted intracellular proteins Evidence at protein level HPA038487, HPA057562 Supported Supported Nucleus
Nucleoli
Cytosol Liver cancer:3.10e-7 (unfavourable) Expressed in all Expressed in all prostate,seminal vesicle: 12.2 SAMD15 C14orf174, FAM15A, FLJ35963 ENSG00000100583 Sterile alpha motif domain containing 15 14 77376689-77391497 Predicted intracellular proteins Evidence at protein level HPA030673, HPA030677 Approved Approved Nucleus
Nuclear membrane
Nucleoli Mixed Tissue enhanced testis: 31.9 fallopian tube: 7.3 SAPCD2 C9orf140, p42.3 ENSG00000186193 Suppressor APC domain containing 2 9 137062124-137070588 Predicted intracellular proteins Evidence at protein level HPA044154 Approved Supported Nucleus
Nucleoli
Cytosol Lung cancer:5.88e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 12.9 small intestine: 4.9 SCNN1G ENaCgamma, SCNEG ENSG00000166828 Sodium channel, non voltage gated 1 gamma subunit 16 23182715-23216883 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA071194 Approved Nucleoplasm
Nucleoli
Plasma membrane Renal cancer:3.20e-7 (unfavourable) Tissue enhanced Tissue enhanced cervix, uterine: 24.5;kidney: 46.4 thyroid gland: 9.5 SDHAF2 C11orf79, FLJ20487, PGL2, SDH5 ENSG00000167985 Succinate dehydrogenase complex assembly factor 2 11 61430042-61447529 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039464, HPA039732 Supported Supported Nucleoli
Mitochondria
Cytosol Expressed in all Expressed in all fallopian tube: 35.7 SH3TC1 FLJ20356 ENSG00000125089 SH3 domain and tetratricopeptide repeats 1 4 8182072-8241803 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA038132, HPA056807 Uncertain Approved Nucleus
Nucleoli
Cytosol Expressed in all Mixed spleen: 12.8 SIRT2 SIR2L ENSG00000068903 Sirtuin 2 19 38878555-38899862 Cancer-related genes, Predicted intracellular proteins Evidence at protein level CAB004573, HPA011165 Approved Approved Nucleus
Nucleoli
Cytosol Endometrial cancer:7.20e-7 (unfavourable) Expressed in all Expressed in all cerebral cortex: 84.2 SLBP HBP ENSG00000163950 Stem-loop binding protein 4 1692800-1712555 Predicted intracellular proteins Evidence at protein level HPA019254, HPA061670 Supported Supported Nucleus
Nucleoli
Cytosol Liver cancer:2.29e-5 (unfavourable) Expressed in all Expressed in all testis: 130.2 SMAD2 JV18-1, MADH2, MADR2 ENSG00000175387 SMAD family member 2 18 47808957-47931146 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level CAB025507, HPA067203, CAB073546 Approved Supported Nucleus
Nucleoli
Cytosol Liver cancer:9.44e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 126.1 SMIM20 C4orf52 ENSG00000250317 Small integral membrane protein 20 4 25861830-25929874 Predicted membrane proteins Evidence at protein level HPA016552 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:8.97e-5 (favourable) Expressed in all Expressed in all epididymis: 86.3 SMPDL3A ASM3A, ASML3a, FLJ20177, yR36GH4.1 ENSG00000172594 Sphingomyelin phosphodiesterase, acid-like 3A 6 122789049-122809720 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA030148 Uncertain Approved Nucleus
Nucleoli
Mitochondria Colorectal cancer:6.11e-4 (favourable) Expressed in all Expressed in all small intestine: 83.5 SNX10 ENSG00000086300 Sorting nexin 10 7 26291895-26374329 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA015605, HPA064782 Approved Approved Nucleus
Nucleoli
Microtubules Renal cancer:8.06e-5 (unfavourable), Glioma:9.81e-5 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 94.6 lung: 60.7 SNX30 ATG24A ENSG00000148158 Sorting nexin family member 30 9 112750838-112881671 Predicted intracellular proteins Evidence at protein level HPA019346 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:1.01e-7 (favourable) Expressed in all Mixed lung: 32.2 SOS1 GF1, GINGF, HGF ENSG00000115904 Son of sevenless homolog 1 (Drosophila) 2 38981396-39124345 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level CAB005396, HPA012613 Uncertain Uncertain Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all parathyroid gland: 40.3 SPG11 FLJ21439, KIAA1840 ENSG00000104133 Spastic paraplegia 11 (autosomal recessive) 15 44562696-44663678 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA040412, HPA040947 Approved Supported Nucleoli
Plasma membrane
Cytosol Renal cancer:6.28e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 49.0 SPOCD1 FLJ25348, PPP1R146 ENSG00000134668 SPOC domain containing 1 1 31790422-31816051 Predicted intracellular proteins Evidence at protein level HPA031713, HPA031714, HPA031715 Approved Approved Nucleus
Nucleoli
Cytosol Urothelial cancer:4.05e-5 (favourable) Group enriched Tissue enhanced testis: 14.1;urinary bladder: 10.3 appendix: 4.5 SPOCK3 testican-3 ENSG00000196104 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 4 166733384-167234796 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA075020 Approved Nucleus
Nucleoli
Golgi apparatus Tissue enhanced Tissue enriched 7 parathyroid gland: 791.1 prostate: 113.9 SS18L2 KIAA-iso ENSG00000008324 Synovial sarcoma translocation gene on chromosome 18-like 2 3 42581840-42595114 Predicted intracellular proteins Evidence at protein level HPA047377 Uncertain Approved Nucleus
Nucleoli
Mitochondria Lung cancer:7.03e-4 (favourable) Expressed in all Expressed in all lymph node: 58.8 STARD13 ARHGAP37, DLC2, GT650, LINC00464 ENSG00000133121 StAR-related lipid transfer (START) domain containing 13 13 33103135-33350630 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039535, HPA058867 Supported Approved Nuclear membrane
Nucleoli
Cytosol Renal cancer:1.23e-4 (unfavourable) Expressed in all Mixed placenta: 35.0 STK33 ENSG00000130413 Serine/threonine kinase 33 11 8391868-8594289 Enzymes, Predicted intracellular proteins Evidence at protein level HPA015742, HPA056855 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:4.89e-6 (favourable) Mixed Tissue enhanced fallopian tube: 66.1;testis: 92.6 parathyroid gland: 42.5 SUZ12 CHET9, JJAZ1, KIAA0160 ENSG00000178691 SUZ12 polycomb repressive complex 2 subunit 17 31937018-32001045 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA057436 Approved Approved Nucleus
Nucleoli
Nuclear bodies Expressed in all Expressed in all testis: 50.5 SYCE3 C22orf41 ENSG00000217442 Synaptonemal complex central element protein 3 22 50551112-50562905 Predicted intracellular proteins Evidence at protein level HPA047813 Approved Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enriched 38 testis: 116.2 thyroid gland: 3.0 TACSTD2 EGP-1, GA733-1, M1S1, TROP2 ENSG00000184292 Tumor-associated calcium signal transducer 2 1 58575423-58577773 Disease related genes, Predicted membrane proteins Evidence at protein level HPA043104, HPA055067, CAB072852 Supported Supported Nucleoli
Vesicles
Plasma membrane Renal cancer:3.99e-4 (favourable) Mixed Tissue enhanced esophagus: 315.1 skin: 210.1 TAOK2 KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2 ENSG00000149930 TAO kinase 2 16 29973641-29992261 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA010650 Approved Supported Nucleus
Nucleoli
Cytosol Endometrial cancer:3.87e-5 (favourable), Colorectal cancer:2.51e-4 (unfavourable), Renal cancer:3.66e-4 (favourable), Pancreatic cancer:4.78e-4 (favourable) Expressed in all Expressed in all testis: 36.9 TGDS SDR2E1, TDPGD ENSG00000088451 TDP-glucose 4,6-dehydratase 13 94574051-94596257 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA039927, HPA040857 Approved Approved Nucleus
Nucleoli
Intermediate filaments Prostate cancer:2.48e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 21.6 TICAM1 MGC35334, PRVTIRB, TICAM-1, TRIF ENSG00000127666 Toll-like receptor adaptor molecule 1 19 4815932-4831704 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA042460 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Lung cancer:3.48e-4 (unfavourable), Endometrial cancer:4.81e-4 (favourable) Expressed in all Expressed in all esophagus: 22.1 TIFA MGC20791, T2BP, T6BP, TIFAA ENSG00000145365 TRAF-interacting protein with forkhead-associated domain 4 112274542-112285903 Predicted intracellular proteins Evidence at protein level HPA045889 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all lymph node: 38.1 TIGD1 EEYORE ENSG00000221944 Tigger transposable element derived 1 2 232547968-232550592 Predicted intracellular proteins Evidence at protein level HPA041717 Approved Supported Nucleus
Nucleoli
Nuclear bodies Renal cancer:4.41e-5 (unfavourable) Expressed in all Expressed in all testis: 18.1 TLDC1 KIAA1609 ENSG00000140950 TBC/LysM-associated domain containing 1 16 84476421-84554033 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA041020 Approved Approved Nucleus
Nucleoli
Cytosol Lung cancer:1.03e-5 (unfavourable), Pancreatic cancer:7.05e-5 (unfavourable) Expressed in all Mixed placenta: 15.4 TMA7 CCDC72, HSPC016 ENSG00000232112 Translation machinery associated 7 homolog 3 48440257-48444208 Predicted intracellular proteins Evidence at protein level HPA047397 Approved Approved Nucleus
Nucleoli
Nuclear bodies Lung cancer:8.33e-4 (favourable) Expressed in all Expressed in all epididymis: 420.8 TMEM108 CT124, MGC3040 ENSG00000144868 Transmembrane protein 108 3 133038391-133397792 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA063350 Uncertain Approved Nucleoli
Vesicles
Cytosol Tissue enhanced Tissue enhanced testis: 25.8 cerebral cortex: 22.0 TNNT2 CMD1D, CMH2, CMPD2 ENSG00000118194 Troponin T type 2 (cardiac) 1 201359008-201377762 Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins Evidence at protein level CAB015371, HPA015774, HPA017888 Supported Uncertain Nucleus
Nucleoli
Focal adhesion sites Mixed Tissue enriched 199 heart muscle: 5036.0 skin: 25.2 TOX4 C14orf92, KIAA0737, LCP1 ENSG00000092203 TOX high mobility group box family member 4 14 21476597-21499175 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017880, HPA027551 Approved Approved Nucleus
Nucleoli
Vesicles Renal cancer:8.38e-5 (favourable), Liver cancer:3.46e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 34.8 TRDMT1 DNMT2, RNMT1 ENSG00000107614 TRNA aspartic acid methyltransferase 1 10 17142254-17202054 Enzymes, Predicted intracellular proteins Evidence at protein level CAB009468, HPA036945, HPA036946 Approved Approved Nucleus
Nucleoli
Centrosome Mixed Mixed parathyroid gland: 8.5 TRIB3 C20orf97, dJ1103G7.3, TRB3 ENSG00000101255 Tribbles pseudokinase 3 20 362835-397559 Enzymes, Predicted intracellular proteins Evidence at protein level HPA055442 Supported Nucleus
Nuclear membrane
Nucleoli Renal cancer:2.07e-13 (unfavourable), Liver cancer:6.75e-5 (unfavourable), Head and neck cancer:1.70e-4 (unfavourable) Expressed in all Tissue enhanced thyroid gland: 51.3 liver: 12.5 TSG101 TSG10, VPS23 ENSG00000074319 Tumor susceptibility 101 11 18468336-18527232 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB004283, HPA006161 Approved Supported Nucleoli
Plasma membrane
Cytosol Liver cancer:3.74e-6 (unfavourable), Renal cancer:5.52e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 80.4 TSPYL6 ENSG00000178021 TSPY-like 6 2 54253184-54256272 Predicted intracellular proteins Evidence at protein level HPA034699, HPA034700 Supported Approved Nucleoli
Centrosome
Cytosol Tissue enriched Tissue enriched 389 testis: 38.8 all non-specific tissues: 0.0 TSSC1 ENSG00000032389 Tumor suppressing subtransferable candidate 1 2 3188925-3377882 Predicted intracellular proteins Evidence at protein level HPA031231, HPA031232, HPA031233, HPA031234 Approved Supported Nucleus
Nucleoli
Intermediate filaments Liver cancer:3.67e-7 (unfavourable) Expressed in all Expressed in all thyroid gland: 34.7 TSSK3 SPOGA3, STK22C ENSG00000162526 Testis-specific serine kinase 3 1 32351521-32364312 Enzymes, Predicted intracellular proteins Evidence at protein level HPA037516 Uncertain Approved Nucleus
Nucleoli
Nuclear bodies Not detected Tissue enhanced testis: 25.2 parathyroid gland: 6.4 TTC3 DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII ENSG00000182670 Tetratricopeptide repeat domain 3 21 37073226-37203112 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA016810, HPA023964, HPA036304 Uncertain Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all thyroid gland: 107.0 TUB rd5 ENSG00000166402 Tubby bipartite transcription factor 11 8019244-8106112 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA017997, HPA049019 Uncertain Approved Nucleoli
Microtubule organizing center
Centrosome Renal cancer:2.35e-5 (favourable), Pancreatic cancer:2.85e-4 (favourable) Mixed Mixed cerebral cortex: 51.5 TULP3 TUBL3 ENSG00000078246 Tubby like protein 3 12 2877223-2941140 Predicted intracellular proteins Evidence at protein level HPA015285, HPA018496 Uncertain Supported Nucleus
Nucleoli
Plasma membrane Liver cancer:7.97e-5 (unfavourable), Endometrial cancer:2.99e-4 (favourable), Renal cancer:7.18e-4 (unfavourable) Expressed in all Expressed in all ovary: 46.4 TXN TRX ENSG00000136810 Thioredoxin 9 110243811-110256640 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB008678, HPA047478, HPA055752 Supported Validated Nucleus
Nucleoli
Cytosol Endometrial cancer:3.40e-6 (favourable) Expressed in all Expressed in all esophagus: 705.8 UPF3B HUPF3B, MRX62, RENT3B, UPF3X ENSG00000125351 UPF3 regulator of nonsense transcripts homolog B (yeast) X 119834022-119852998 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA001592, HPA001800, HPA001882 Approved Validated Nucleus
Nucleoli
Cytosol Renal cancer:1.44e-7 (unfavourable), Liver cancer:1.52e-6 (unfavourable), Melanoma:5.39e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex,endometrium: 18.4 USF3 KIAA2018 ENSG00000176542 Upstream transcription factor family member 3 3 113648385-113696646 Predicted intracellular proteins Evidence at protein level HPA029243, HPA029245 Uncertain Uncertain Nucleoplasm
Nucleoli
Centrosome Renal cancer:1.74e-6 (favourable) Expressed in all Mixed parathyroid gland: 13.4 UTP18 CGI-48, WDR50 ENSG00000011260 UTP18 small subunit (SSU) processome component 17 51260528-51297936 Predicted intracellular proteins Evidence at protein level HPA052378 Approved Supported Nucleus
Nuclear membrane
Nucleoli Liver cancer:1.99e-4 (unfavourable), Colorectal cancer:3.33e-4 (favourable) Expressed in all Expressed in all testis: 105.6 VEPH1 FLJ12604, KIAA1692 ENSG00000197415 Ventricular zone expressed PH domain-containing 1 3 157259742-157533619 Predicted intracellular proteins Evidence at protein level HPA026645 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:7.75e-9 (favourable) Mixed Tissue enhanced adrenal gland: 26.8;kidney: 28.5;lung: 43.9 epididymis: 21.0 VPS51 ANG2, ANG3, C11orf2, C11orf3, FFR ENSG00000149823 Vacuolar protein sorting 51 homolog (S. cerevisiae) 11 65089324-65111860 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039650, HPA061447 Uncertain Approved Nucleoli
Golgi apparatus
Vesicles Renal cancer:2.41e-9 (favourable) Expressed in all Expressed in all ovary: 102.0 VSIG4 Z39IG ENSG00000155659 V-set and immunoglobulin domain containing 4 X 66021738-66040125 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA003903, CAB026000 Approved Uncertain Nucleoli
Plasma membrane
Cytosol Renal cancer:1.95e-6 (unfavourable), Colorectal cancer:1.34e-4 (unfavourable) Expressed in all Expressed in all lung: 243.3 WDFY3 ALFY, KIAA0993, ZFYVE25 ENSG00000163625 WD repeat and FYVE domain containing 3 4 84669610-84966391 Predicted intracellular proteins Evidence at protein level HPA042734, HPA048572 Approved Approved Nucleoli
Plasma membrane
Cytosol Renal cancer:3.64e-5 (favourable), Stomach cancer:9.35e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 35.6 WDR12 FLJ10881, YTM1 ENSG00000138442 WD repeat domain 12 2 202874782-203014798 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA036389 Uncertain Approved Nucleoli
Plasma membrane
Cytosol Liver cancer:2.57e-6 (unfavourable) Expressed in all Mixed testis: 7.3 WDR3 DIP2, FLJ12796, UTP12 ENSG00000065183 WD repeat domain 3 1 117929720-117966542 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA027509, HPA054354 Approved Supported Nucleus
Nuclear membrane
Nucleoli Liver cancer:7.33e-5 (unfavourable), Pancreatic cancer:8.82e-4 (unfavourable) Expressed in all Expressed in all testis: 22.3 WDSUB1 FLJ36175, UBOX6, WDSAM1 ENSG00000196151 WD repeat, sterile alpha motif and U-box domain containing 1 2 159235793-159286799 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA036840, HPA058172 Uncertain Approved Nucleus
Nucleoli
Cytosol Liver cancer:2.67e-4 (unfavourable), Cervical cancer:3.35e-4 (favourable) Expressed in all Expressed in all thyroid gland: 27.9 ZBED9 Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452 ENSG00000232040 Zinc finger, BED-type containing 9 6 28571630-28616212 Predicted intracellular proteins Evidence at protein level HPA007246 Uncertain Approved Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enhanced testis: 18.7 epididymis: 4.5 ZBTB14 ZFP161, ZNF478 ENSG00000198081 Zinc finger and BTB domain containing 14 18 5289019-5297053 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050758, HPA070819 Uncertain Validated Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all lymph node: 29.3 ZCCHC2 C18orf49, FLJ20222, FLJ20281, KIAA1744 ENSG00000141664 Zinc finger, CCHC domain containing 2 18 62523007-62587709 Predicted intracellular proteins Evidence at protein level HPA040943 Uncertain Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all testis: 22.3 ZEB2 KIAA0569, SIP-1, SIP1, ZFHX1B ENSG00000169554 Zinc finger E-box binding homeobox 2 2 144384081-144524583 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003456 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:6.04e-5 (unfavourable) Expressed in all Expressed in all cerebral cortex: 95.9 ZFAND2B AIRAPL ENSG00000158552 Zinc finger, AN1-type domain 2B 2 219195237-219209651 Predicted intracellular proteins Evidence at protein level HPA035159, HPA035160 Uncertain Approved Nucleus
Nucleoli
Cytosol Pancreatic cancer:9.38e-4 (favourable) Expressed in all Expressed in all thyroid gland: 68.1 ZFP41 FLJ00028, FLJ38705, ZNF753 ENSG00000181638 ZFP41 zinc finger protein 8 143246821-143262705 Predicted intracellular proteins Evidence at transcript level HPA047232, HPA056268 Uncertain Uncertain Nucleus
Nucleoli
Plasma membrane Liver cancer:3.46e-5 (unfavourable) Expressed in all Mixed cerebral cortex: 7.5 ZNF106 SH3BP3, ZFP106, ZNF474 ENSG00000103994 Zinc finger protein 106 15 42412823-42491123 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA054267 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all skeletal muscle: 144.2 ZNF121 D19S204, ZHC32, ZNF20 ENSG00000197961 Zinc finger protein 121 19 9560353-9584533 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054961 Uncertain Uncertain Nucleoplasm
Nucleoli
Centrosome Urothelial cancer:5.75e-5 (favourable), Ovarian cancer:6.59e-5 (favourable), Renal cancer:1.01e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 23.1 ZNF354A EZNF, HKL1, KID-1, KID1, TCF17 ENSG00000169131 Zinc finger protein 354A 5 178711592-178730702 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052043 Approved Supported Nucleus
Nucleoli
Cytosol Renal cancer:3.45e-6 (unfavourable), Ovarian cancer:8.28e-4 (favourable) Expressed in all Expressed in all testis: 16.7 ZNF461 GIOT-1, MGC33911 ENSG00000197808 Zinc finger protein 461 19 36637192-36666853 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA021139 Uncertain Approved Nucleus
Nucleoli
Golgi apparatus Endometrial cancer:3.64e-4 (unfavourable) Expressed in all Mixed thyroid gland: 6.1 ZNF571 HSPC059 ENSG00000180479 Zinc finger protein 571 19 37554782-37594790 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA054762 Approved Nucleus
Nucleoli
Plasma membrane Mixed Tissue enriched 5 thyroid gland: 130.2 testis: 25.9 ZNF597 FLJ33071, HIT-4 ENSG00000167981 Zinc finger protein 597 16 3432422-3443542 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001556 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Mixed testis: 7.3 ZNF678 MGC42493 ENSG00000181450 Zinc finger protein 678 1 227563543-227677443 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028507 Uncertain Approved Nucleoli
Mitochondria
Cytosol Expressed in all Mixed thyroid gland: 9.0 ZNF691 Zfp691 ENSG00000164011 Zinc finger protein 691 1 42846573-42852477 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA062527 Approved Approved Nucleus
Nucleoli
Vesicles Liver cancer:7.33e-6 (unfavourable), Pancreatic cancer:6.25e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 21.4 ZNF750 FLJ13841, Zfp750 ENSG00000141579 Zinc finger protein 750 17 82829435-82840578 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level HPA021573, HPA023012 Approved Approved Nucleus
Nucleoli
Vesicles Mixed Tissue enhanced esophagus: 60.7;skin: 54.5 salivary gland: 13.0 ZNF787 ENSG00000142409 Zinc finger protein 787 19 56087366-56121280 Predicted intracellular proteins Evidence at protein level HPA035140 Supported Approved Nucleus
Nucleoli
Mitochondria Expressed in all Expressed in all spleen: 19.7 ZNF793 ENSG00000188227 Zinc finger protein 793 19 37506939-37548762 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034781 Uncertain Approved Nucleus
Nucleoli
Cytosol Mixed Mixed testis: 16.8